Dopamine function in obsessive compulsive disorder: cortisol response to acute apomorphine stimulation (Q60441442)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10737700 AND SRC:MED&resulttype=core&format=json

5 November 2019

title

Dopamine function in obsessive compulsive disorder: cortisol response to acute apomorphine stimulation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10737700 AND SRC:MED&resulttype=core&format=json

5 November 2019

0 references

0 references

1 reference

obsessive-compulsive disorder

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10737700 AND SRC:MED&resulttype=core&format=json

5 November 2019

author name string

F Brambilla

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10737700 AND SRC:MED&resulttype=core&format=json

5 November 2019

R Bussi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10737700 AND SRC:MED&resulttype=core&format=json

5 November 2019

L Bellodi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10737700 AND SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10737700 AND SRC:MED&resulttype=core&format=json

5 November 2019

published in

Psychoneuroendocrinology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10737700 AND SRC:MED&resulttype=core&format=json

5 November 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10737700 AND SRC:MED&resulttype=core&format=json

5 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10737700 AND SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

301-310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10737700 AND SRC:MED&resulttype=core&format=json

Activational effects of gonadal steroids on hypothalamo-pituitary-adrenal regulation in the rat disclosed by response to dexamethasone suppression.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Massive doses of trifluoperazine in the treatment of compulsive rituals

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Corticotropin releasing factor stimulation test in obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Plasma catecholamines and their metabolites in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats.

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Dopamine function in obsessive-compulsive disorder: growth hormone response to apomorphine stimulation.

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Dissociation of growth hormone and cortisol release following apomorphine

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Amphetamine-induced perseverative behavior in a radial arm maze following DSP4 or 6-OHDA pretreatment

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Production of corticotrophin releasing hormone by the isolated hypothalamus of the rat

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Cocaine stimulates rat hypothalamic corticotropin-releasing hormone secretion in vitro

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Basal and stress-induced corticosterone secretion is decreased by lesion of mesencephalic dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Neurotransmitter Regulation of Growth Hormone and ACTH in the Rhesus Monkey: Effects of Biogenic Amines

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

HPA axis disturbance in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotonergic afferences

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

D2-agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Effects of neurotransmitters on the release of corticotropin releasing hormone (CRH) by rat hypothalamic tissue in vitro

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Estradiol abolishes autologous down regulation of glucocorticoid receptors in brain

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Neuroendocrine responses to intravenous L-tryptophan in obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Elevation of Serum Corticosterone Concentrations in Rats by Pergolide and Other Dopamine Agonists

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Urinary free cortisol levels in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

A neuroendocrine role in cocaine reinforcement

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

The role of serotonin and dopamine in the pathophysiology of obsessive compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

1 reference

7 January 2021

The role of biogenic amines in the regulation of growth hormone and corticotropin secretion in the trained conscious dog

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Increase in plasma ACTH after dopaminergic stimulation in rats

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Apomorphine injection stimulates beta-endorphin, adrenocorticotropin, and cortisol release in healthy man

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Dopamine receptor modulation of corticosterone secretion in neonatal and adult rats

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Apomorphine in the evaluation of dopaminergic function in man.

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Multihormonal responses to apomorphine in mental illness

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Circadian rhythms of melatonin, cortisol and prolactin in patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Successful treatment of obsessive-compulsive disorder with loxapine

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Molecular biology of dopamine receptors

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Effects of metoclopramide on plasma corticosteroid levels in sheep

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

Clomipramine treatment of obsessive-compulsive disorder. II. Biochemical aspects

1 reference

https://api.crossref.org/works/10.1016/S0306-4530(99)50061-X

7 January 2021

10.1016/S0306-4530(99)00061-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10737700 AND SRC:MED&resulttype=core&format=json

5 November 2019

1 reference